or Try an Advanced Search...

    Technical Analysis for BPTH - Bio-Path Holdings Inc

    Grade Last Price % Change Price Change
    F 2.70 -2.27% -0.06
    BPTH closed down 8.0 percent on Wednesday, May 8, 2024, on 4 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: May 10
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical BPTH trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion -2.27%
    Oversold Stochastic Weakness -2.27%
    20 DMA Resistance Bearish -10.09%
    Stochastic Buy Signal Bullish -10.09%
    Wide Bands Range Expansion -10.09%
    Oversold Stochastic Weakness -10.09%
    Narrow Range Bar Range Contraction -0.47%
    Wide Bands Range Expansion -0.47%
    Gapped Up Strength -0.47%
    Oversold Stochastic Weakness -0.47%
    Older End-of-Day Signals for BPTH ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 2 hours ago
    Fell Below Previous Day's Low about 2 hours ago
    Down 2 % about 2 hours ago
    Down 1% about 2 hours ago
    Fell Below 10 DMA about 2 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    BPTH Chart by TradingView
    Basic chart:

    Profile

    Bio-Path Holdings, Inc., a biotechnology company, focuses on developing therapeutic products utilizing its proprietary liposomal delivery technology to systemically distribute nucleic acid drugs throughout the human body with a simple intravenous transfusion. Its lead product candidate, Liposomal Grb-2, is in a Phase I study for blood cancers and in preclinical studies for triple negative and inflammatory breast cancers. The company's other drug candidate, Liposomal Bcl-2, is ready for the clinic where it would be evaluated in lymphoma and solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Houston, Texas.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Biotechnology Solid Tumors Acid Breast Cancer Lymphoma Cell Biology Treatment Of Breast Cancer Therapeutic Products Oncogenes Blood Cancers Apoptosis

    Is BPTH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 1 Looking Into Bio-Path Hldgs's Recent Short Interest
    Apr 24 Bio-Path files to sell 484K shares of common stock for holders
    Apr 19 Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    Apr 19 Bio-Path (BPTH) Rises on Upbeat Updates From Blood Cancer Study
    Apr 18 Bio-Path announces $1.2M registered direct offering priced at-the-market
    Apr 18 Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    Apr 18 Bio-Path shares rally after clinical trial progress of BP1002
    Apr 18 Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients
    Apr 15 Bio-Path gets newly issued patents in Mexico, Australia and Japan
    Apr 15 Bio-Path Holdings Expands Global Patent Portfolio
    See more BPTH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 44.8
    52 Week Low 2.35
    Average Volume 1,809,318
    200-Day Moving Average 8.36
    50-Day Moving Average 4.12
    20-Day Moving Average 2.98
    10-Day Moving Average 2.75
    Average True Range 0.54
    RSI (14) 40.48
    ADX 24.75
    +DI 32.06
    -DI 18.64
    Chandelier Exit (Long, 3 ATRs) 6.06
    Chandelier Exit (Short, 3 ATRs) 3.96
    Upper Bollinger Bands 3.90
    Lower Bollinger Band 2.05
    Percent B (%b) 0.38
    BandWidth 62.34
    MACD Line -0.43
    MACD Signal Line -0.51
    MACD Histogram 0.0838
    Fundamentals Value
    Market Cap 34.09 Million
    Num Shares 12.4 Million
    EPS -2.00
    Price-to-Earnings (P/E) Ratio -1.38
    Price-to-Sales 0.00
    Price-to-Book 2.20
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.18
    Resistance 3 (R3) 3.20 3.09 3.11
    Resistance 2 (R2) 3.09 2.98 3.08 3.09
    Resistance 1 (R1) 2.92 2.91 2.87 2.90 3.06
    Pivot Point 2.81 2.81 2.78 2.80 2.81
    Support 1 (S1) 2.64 2.70 2.59 2.62 2.46
    Support 2 (S2) 2.53 2.63 2.52 2.43
    Support 3 (S3) 2.36 2.53 2.41
    Support 4 (S4) 2.34